The Market Reports

Index

1 Aciclovir Market Overview
1.1 Product Overview and Scope of Aciclovir
1.2 Aciclovir Segment by Type
1.2.1 Global Aciclovir Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Generic
1.2.3 Patent
1.3 Aciclovir Segment by Application
1.3.1 Aciclovir Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Aciclovir Market Size Estimates and Forecasts
1.4.1 Global Aciclovir Revenue 2016-2027
1.4.2 Global Aciclovir Sales 2016-2027
1.4.3 Aciclovir Market Size by Region: 2016 Versus 2021 Versus 2027

2 Aciclovir Market Competition by Manufacturers
2.1 Global Aciclovir Sales Market Share by Manufacturers (2016-2021)
2.2 Global Aciclovir Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Aciclovir Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Aciclovir Manufacturing Sites, Area Served, Product Type
2.5 Aciclovir Market Competitive Situation and Trends
2.5.1 Aciclovir Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Aciclovir Players Market Share by Revenue
2.5.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aciclovir Retrospective Market Scenario by Region
3.1 Global Aciclovir Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Aciclovir Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Aciclovir Market Facts & Figures by Country
3.3.1 North America Aciclovir Sales by Country
3.3.2 North America Aciclovir Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Aciclovir Market Facts & Figures by Country
3.4.1 Europe Aciclovir Sales by Country
3.4.2 Europe Aciclovir Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Aciclovir Market Facts & Figures by Region
3.5.1 Asia Pacific Aciclovir Sales by Region
3.5.2 Asia Pacific Aciclovir Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Aciclovir Market Facts & Figures by Country
3.6.1 Latin America Aciclovir Sales by Country
3.6.2 Latin America Aciclovir Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Aciclovir Market Facts & Figures by Country
3.7.1 Middle East and Africa Aciclovir Sales by Country
3.7.2 Middle East and Africa Aciclovir Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Aciclovir Historic Market Analysis by Type
4.1 Global Aciclovir Sales Market Share by Type (2016-2021)
4.2 Global Aciclovir Revenue Market Share by Type (2016-2021)
4.3 Global Aciclovir Price by Type (2016-2021)

5 Global Aciclovir Historic Market Analysis by Application
5.1 Global Aciclovir Sales Market Share by Application (2016-2021)
5.2 Global Aciclovir Revenue Market Share by Application (2016-2021)
5.3 Global Aciclovir Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Greater Pharma
6.1.1 Greater Pharma Corporation Information
6.1.2 Greater Pharma Description and Business Overview
6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Greater Pharma Product Portfolio
6.1.5 Greater Pharma Recent Developments/Updates
6.2 LBS Labs
6.2.1 LBS Labs Corporation Information
6.2.2 LBS Labs Description and Business Overview
6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.2.4 LBS Labs Product Portfolio
6.2.5 LBS Labs Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GlaxoSmithKline Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Lex Ano
6.4.1 Lex Ano Corporation Information
6.4.2 Lex Ano Description and Business Overview
6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lex Ano Product Portfolio
6.4.5 Lex Ano Recent Developments/Updates
6.5 Salutas
6.5.1 Salutas Corporation Information
6.5.2 Salutas Description and Business Overview
6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Salutas Product Portfolio
6.5.5 Salutas Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Stada Nordic
6.8.1 Stada Nordic Corporation Information
6.8.2 Stada Nordic Description and Business Overview
6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Stada Nordic Product Portfolio
6.8.5 Stada Nordic Recent Developments/Updates
6.9 Cimed Industria de Medicamentos
6.9.1 Cimed Industria de Medicamentos Corporation Information
6.9.2 Cimed Industria de Medicamentos Description and Business Overview
6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Cimed Industria de Medicamentos Product Portfolio
6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
6.10 Reman Drug
6.10.1 Reman Drug Corporation Information
6.10.2 Reman Drug Description and Business Overview
6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Reman Drug Product Portfolio
6.10.5 Reman Drug Recent Developments/Updates
6.11 L.E.T.I.
6.11.1 L.E.T.I. Corporation Information
6.11.2 L.E.T.I. Aciclovir Description and Business Overview
6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.11.4 L.E.T.I. Product Portfolio
6.11.5 L.E.T.I. Recent Developments/Updates
6.12 Nichi-Iko Pharmaceutical
6.12.1 Nichi-Iko Pharmaceutical Corporation Information
6.12.2 Nichi-Iko Pharmaceutical Aciclovir Description and Business Overview
6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Nichi-Iko Pharmaceutical Product Portfolio
6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.13 Choseido Pharmaceutical
6.13.1 Choseido Pharmaceutical Corporation Information
6.13.2 Choseido Pharmaceutical Aciclovir Description and Business Overview
6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Choseido Pharmaceutical Product Portfolio
6.13.5 Choseido Pharmaceutical Recent Developments/Updates
6.14 Shiono Kemikaru
6.14.1 Shiono Kemikaru Corporation Information
6.14.2 Shiono Kemikaru Aciclovir Description and Business Overview
6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Shiono Kemikaru Product Portfolio
6.14.5 Shiono Kemikaru Recent Developments/Updates
6.15 Towa Yakuhin
6.15.1 Towa Yakuhin Corporation Information
6.15.2 Towa Yakuhin Aciclovir Description and Business Overview
6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Towa Yakuhin Product Portfolio
6.15.5 Towa Yakuhin Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Aciclovir Description and Business Overview
6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Wockhardt Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Takata Pharmaceutical
6.17.1 Takata Pharmaceutical Corporation Information
6.17.2 Takata Pharmaceutical Aciclovir Description and Business Overview
6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Takata Pharmaceutical Product Portfolio
6.17.5 Takata Pharmaceutical Recent Developments/Updates
6.18 Aliud
6.18.1 Aliud Corporation Information
6.18.2 Aliud Aciclovir Description and Business Overview
6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Aliud Product Portfolio
6.18.5 Aliud Recent Developments/Updates
6.19 Amneal Pharma
6.19.1 Amneal Pharma Corporation Information
6.19.2 Amneal Pharma Aciclovir Description and Business Overview
6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Amneal Pharma Product Portfolio
6.19.5 Amneal Pharma Recent Developments/Updates
6.20 Apotex
6.20.1 Apotex Corporation Information
6.20.2 Apotex Aciclovir Description and Business Overview
6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Apotex Product Portfolio
6.20.5 Apotex Recent Developments/Updates
6.21 Arrow
6.21.1 Arrow Corporation Information
6.21.2 Arrow Aciclovir Description and Business Overview
6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Arrow Product Portfolio
6.21.5 Arrow Recent Developments/Updates
6.22 Laboratoires Servier
6.22.1 Laboratoires Servier Corporation Information
6.22.2 Laboratoires Servier Aciclovir Description and Business Overview
6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Laboratoires Servier Product Portfolio
6.22.5 Laboratoires Servier Recent Developments/Updates
6.23 Sanofi
6.23.1 Sanofi Corporation Information
6.23.2 Sanofi Aciclovir Description and Business Overview
6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Sanofi Product Portfolio
6.23.5 Sanofi Recent Developments/Updates
6.24 Mylan
6.24.1 Mylan Corporation Information
6.24.2 Mylan Aciclovir Description and Business Overview
6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Mylan Product Portfolio
6.24.5 Mylan Recent Developments/Updates
6.25 Orion Pharma
6.25.1 Orion Pharma Corporation Information
6.25.2 Orion Pharma Aciclovir Description and Business Overview
6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Orion Pharma Product Portfolio
6.25.5 Orion Pharma Recent Developments/Updates
6.26 Pfizer
6.26.1 Pfizer Corporation Information
6.26.2 Pfizer Aciclovir Description and Business Overview
6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Pfizer Product Portfolio
6.26.5 Pfizer Recent Developments/Updates

7 Aciclovir Manufacturing Cost Analysis
7.1 Aciclovir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Aciclovir
7.4 Aciclovir Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Aciclovir Distributors List
8.3 Aciclovir Customers

9 Aciclovir Market Dynamics
9.1 Aciclovir Industry Trends
9.2 Aciclovir Growth Drivers
9.3 Aciclovir Market Challenges
9.4 Aciclovir Market Restraints

10 Global Market Forecast
10.1 Aciclovir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Aciclovir by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Aciclovir by Type (2022-2027)
10.2 Aciclovir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Aciclovir by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Aciclovir by Application (2022-2027)
10.3 Aciclovir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Aciclovir by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Aciclovir by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Aciclovir Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Aciclovir Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Aciclovir Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Aciclovir Covered in This Study
Table 5. Global Aciclovir Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Aciclovir Sales Share by Manufacturers (2016-2021)
Table 7. Global Aciclovir Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Aciclovir Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Aciclovir Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Aciclovir Manufacturing Sites and Area Served
Table 11. Manufacturers Aciclovir Product Type
Table 12. Global Aciclovir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Aciclovir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aciclovir as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Aciclovir Sales by Region (2016-2021) & (K Units)
Table 16. Global Aciclovir Sales Market Share by Region (2016-2021)
Table 17. Global Aciclovir Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Aciclovir Sales by Country (2016-2021) & (K Units)
Table 19. North America Aciclovir Sales Market Share by Country (2016-2021)
Table 20. North America Aciclovir Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Aciclovir Revenue Market Share by Country (2016-2021)
Table 22. Europe Aciclovir Sales by Country (2016-2021) & (K Units)
Table 23. Europe Aciclovir Sales Market Share by Country (2016-2021)
Table 24. Europe Aciclovir Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Aciclovir Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Aciclovir Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Aciclovir Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Aciclovir Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Aciclovir Revenue Market Share by Region (2016-2021)
Table 30. Latin America Aciclovir Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Aciclovir Sales Market Share by Country (2016-2021)
Table 32. Latin America Aciclovir Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Aciclovir Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Aciclovir Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Aciclovir Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Aciclovir Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Aciclovir Revenue Market Share by Country (2016-2021)
Table 38. Global Aciclovir Sales (K Units) by Type (2016-2021)
Table 39. Global Aciclovir Sales Market Share by Type (2016-2021)
Table 40. Global Aciclovir Revenue (Million US$) by Type (2016-2021)
Table 41. Global Aciclovir Revenue Share by Type (2016-2021)
Table 42. Global Aciclovir Price (US$/Unit) by Type (2016-2021)
Table 43. Global Aciclovir Sales (K Units) by Application (2016-2021)
Table 44. Global Aciclovir Sales Market Share by Application (2016-2021)
Table 45. Global Aciclovir Revenue (Million US$) by Application (2016-2021)
Table 46. Global Aciclovir Revenue Share by Application (2016-2021)
Table 47. Global Aciclovir Price (US$/Unit) by Application (2016-2021)
Table 48. Greater Pharma Corporation Information
Table 49. Greater Pharma Description and Business Overview
Table 50. Greater Pharma Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Greater Pharma Aciclovir Product
Table 52. Greater Pharma Recent Developments/Updates
Table 53. LBS Labs Corporation Information
Table 54. LBS Labs Description and Business Overview
Table 55. LBS Labs Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. LBS Labs Aciclovir Product
Table 57. LBS Labs Recent Developments/Updates
Table 58. GlaxoSmithKline Corporation Information
Table 59. GlaxoSmithKline Description and Business Overview
Table 60. GlaxoSmithKline Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. GlaxoSmithKline Aciclovir Product
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. Lex Ano Corporation Information
Table 64. Lex Ano Description and Business Overview
Table 65. Lex Ano Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Lex Ano Aciclovir Product
Table 67. Lex Ano Recent Developments/Updates
Table 68. Salutas Corporation Information
Table 69. Salutas Description and Business Overview
Table 70. Salutas Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Salutas Aciclovir Product
Table 72. Salutas Recent Developments/Updates
Table 73. Novartis Corporation Information
Table 74. Novartis Description and Business Overview
Table 75. Novartis Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Novartis Aciclovir Product
Table 77. Novartis Recent Developments/Updates
Table 78. Teva Corporation Information
Table 79. Teva Description and Business Overview
Table 80. Teva Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Teva Aciclovir Product
Table 82. Teva Recent Developments/Updates
Table 83. Stada Nordic Corporation Information
Table 84. Stada Nordic Description and Business Overview
Table 85. Stada Nordic Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Stada Nordic Aciclovir Product
Table 87. Stada Nordic Recent Developments/Updates
Table 88. Cimed Industria de Medicamentos Corporation Information
Table 89. Cimed Industria de Medicamentos Description and Business Overview
Table 90. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Cimed Industria de Medicamentos Aciclovir Product
Table 92. Cimed Industria de Medicamentos Recent Developments/Updates
Table 93. Reman Drug Corporation Information
Table 94. Reman Drug Description and Business Overview
Table 95. Reman Drug Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Reman Drug Aciclovir Product
Table 97. Reman Drug Recent Developments/Updates
Table 98. L.E.T.I. Corporation Information
Table 99. L.E.T.I. Description and Business Overview
Table 100. L.E.T.I. Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. L.E.T.I. Aciclovir Product
Table 102. L.E.T.I. Recent Developments/Updates
Table 103. Nichi-Iko Pharmaceutical Corporation Information
Table 104. Nichi-Iko Pharmaceutical Description and Business Overview
Table 105. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Nichi-Iko Pharmaceutical Aciclovir Product
Table 107. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 108. Choseido Pharmaceutical Corporation Information
Table 109. Choseido Pharmaceutical Description and Business Overview
Table 110. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Choseido Pharmaceutical Aciclovir Product
Table 112. Choseido Pharmaceutical Recent Developments/Updates
Table 113. Shiono Kemikaru Corporation Information
Table 114. Shiono Kemikaru Description and Business Overview
Table 115. Shiono Kemikaru Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Shiono Kemikaru Aciclovir Product
Table 117. Shiono Kemikaru Recent Developments/Updates
Table 118. Towa Yakuhin Corporation Information
Table 119. Towa Yakuhin Description and Business Overview
Table 120. Towa Yakuhin Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Towa Yakuhin Aciclovir Product
Table 122. Towa Yakuhin Recent Developments/Updates
Table 123. Wockhardt Corporation Information
Table 124. Wockhardt Description and Business Overview
Table 125. Wockhardt Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Wockhardt Aciclovir Product
Table 127. Wockhardt Recent Developments/Updates
Table 128. Takata Pharmaceutical Corporation Information
Table 129. Takata Pharmaceutical Description and Business Overview
Table 130. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Takata Pharmaceutical Aciclovir Product
Table 132. Takata Pharmaceutical Recent Developments/Updates
Table 133. Aliud Corporation Information
Table 134. Aliud Description and Business Overview
Table 135. Aliud Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Aliud Aciclovir Product
Table 137. Aliud Recent Developments/Updates
Table 138. Amneal Pharma Corporation Information
Table 139. Amneal Pharma Description and Business Overview
Table 140. Amneal Pharma Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Amneal Pharma Aciclovir Product
Table 142. Amneal Pharma Recent Developments/Updates
Table 143. Apotex Corporation Information
Table 144. Apotex Description and Business Overview
Table 145. Apotex Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Apotex Aciclovir Product
Table 147. Apotex Recent Developments/Updates
Table 148. Arrow Corporation Information
Table 149. Arrow Description and Business Overview
Table 150. Arrow Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Arrow Aciclovir Product
Table 152. Arrow Recent Developments/Updates
Table 153. Laboratoires Servier Corporation Information
Table 154. Laboratoires Servier Description and Business Overview
Table 155. Laboratoires Servier Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Laboratoires Servier Aciclovir Product
Table 157. Laboratoires Servier Recent Developments/Updates
Table 158. Sanofi Corporation Information
Table 159. Sanofi Description and Business Overview
Table 160. Sanofi Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Sanofi Aciclovir Product
Table 162. Sanofi Recent Developments/Updates
Table 163. Mylan Corporation Information
Table 164. Mylan Description and Business Overview
Table 165. Mylan Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Mylan Aciclovir Product
Table 167. Mylan Recent Developments/Updates
Table 168. Orion Pharma Corporation Information
Table 169. Orion Pharma Description and Business Overview
Table 170. Orion Pharma Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 171. Orion Pharma Aciclovir Product
Table 172. Orion Pharma Recent Developments/Updates
Table 173. Pfizer Corporation Information
Table 174. Pfizer Description and Business Overview
Table 175. Pfizer Aciclovir Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 176. Pfizer Aciclovir Product
Table 177. Pfizer Recent Developments/Updates
Table 178. Production Base and Market Concentration Rate of Raw Material
Table 179. Key Suppliers of Raw Materials
Table 180. Aciclovir Distributors List
Table 181. Aciclovir Customers List
Table 182. Aciclovir Market Trends
Table 183. Aciclovir Growth Drivers
Table 184. Aciclovir Market Restraints
Table 185. Global Aciclovir Sales Forecast by Type (2022-2027) & (K Units)
Table 186. Global Aciclovir Sales Market Share Forecast by Type (2022-2027)
Table 187. Global Aciclovir Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 188. Global Aciclovir Revenue Market Share Forecast by Type (2022-2027)
Table 189. Global Aciclovir Sales Forecast by Application (2022-2027) & (K Units)
Table 190. Global Aciclovir Sales Market Share Forecast by Application (2022-2027)
Table 191. Global Aciclovir Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 192. Global Aciclovir Revenue Market Share Forecast by Application (2022-2027)
Table 193. Global Aciclovir Sales Forecast by Region (2022-2027) & (K Units)
Table 194. Global Aciclovir Sales Market Share Forecast by Region (2022-2027)
Table 195. Global Aciclovir Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 196. Global Aciclovir Revenue Market Share Forecast by Region (2022-2027)
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aciclovir
Figure 2. Global Aciclovir Market Share by Type in 2020 & 2027
Figure 3. Generic Product Picture
Figure 4. Patent Product Picture
Figure 5. Global Aciclovir Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Aciclovir Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Aciclovir Market Size 2016-2027 (US$ Million)
Figure 10. Global Aciclovir Sales 2016-2027 (K Units)
Figure 11. Global Aciclovir Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Aciclovir Sales Share by Manufacturers in 2020
Figure 13. Global Aciclovir Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Aciclovir Players: Market Share by Revenue in 2020
Figure 15. Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Aciclovir Sales Market Share by Region (2016-2021)
Figure 17. Global Aciclovir Sales Market Share by Region in 2020
Figure 18. Global Aciclovir Revenue Market Share by Region (2016-2021)
Figure 19. Global Aciclovir Revenue Market Share by Region in 2020
Figure 20. U.S. Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Aciclovir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Aciclovir by Type (2016-2021)
Figure 45. Sales Market Share of Aciclovir by Application (2016-2021)
Figure 46. Sales Market Share of Aciclovir by Application in 2020
Figure 47. Revenue Share of Aciclovir by Application (2016-2021)
Figure 48. Revenue Share of Aciclovir by Application in 2020
Figure 49. Manufacturing Cost Structure of Aciclovir
Figure 50. Manufacturing Process Analysis of Aciclovir
Figure 51. Aciclovir Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed